Creative Planning’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Creative Planning’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-17,762	Closed	-$4K	–	2159
2019 Q3	$4K	Hold	17,762	–	–	﹤0.01%	1934
2019 Q2	$15K	Hold	17,762	–	–	﹤0.01%	1911
2019 Q1	$41K	Hold	17,762	–	–	﹤0.01%	1794
2018 Q4	$41K	Hold	17,762	–	–	﹤0.01%	1730
2018 Q3	$263K	Buy	+17,762	New	+$282K	﹤0.01%	1491

Other funds holding SNNA

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Creative Planning's SNNA Position: Q4 2019 in Review

Creative Planning sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q4 2019, closing a stake of 17,762 shares — an estimated $4K sold.

Creative Planning first reported a position in SNNA in Q3 2018 and held it in 5 quarters. The position peaked at $263K in Q3 2018. 4 funds tracked by Wall St. Rank hold SNNA as of Q4 2019.

Creative Planning reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Creative Planning sold 17,762 Sienna Biopharmaceuticals, Inc. shares in Q4 2019, an estimated $4K.
Creative Planning first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2018 and held it in 5 quarters.
Creative Planning's Sienna Biopharmaceuticals, Inc. position peaked at $263K in Q3 2018.
4 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q4 2019.

Based on Creative Planning's 13F filing for Q4 2019, filed 30 Jan 2020.